DISCOUNT ZERTIFIKAT - VERTEX PHARMACEUTICALS Stock

Certificat

DE000MG1BSZ2

Market Closed - Börse Stuttgart 15:24:38 2024-05-28 EDT
266.6 EUR -0.15% Intraday chart for DISCOUNT ZERTIFIKAT - VERTEX PHARMACEUTICALS
Current month-0.31%
1 month+0.04%
Date Price Change
24-05-28 266.6 -0.15%
24-05-27 267 -0.04%
24-05-24 267.1 -0.26%
24-05-23 267.8 +0.08%
24-05-22 267.6 +0.36%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 03:24 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying VERTEX PHARMACEUTICALS INCORPORATED
Issuer Morgan Stanley
WKN MG1BSZ
ISINDE000MG1BSZ2
Date issued 2024-04-02
Maturity 2025-03-21 (297 Days)
Parity 1 : 1
Emission price 263.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 267.8
Lowest since issue 260.4

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
More about the company

Ratings for Vertex Pharmaceuticals Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Vertex Pharmaceuticals Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
446.9 USD
Average target price
462.8 USD
Spread / Average Target
+3.57%
Consensus